BRCA1 and triple-negative breast carcinoma: Triple negative breast cancer patients have higher rate of BRCA1/2 (Breast Cancer 1/2) mutation and are sensitive to platinum (because of the deficiencies in the DNA repair mechanism) [30, 31].